Universe Pharmaceuticals Inc (UPC)
2.15
-0.02
(-0.92%)
USD |
NASDAQ |
May 03, 16:00
2.03
-0.12
(-5.58%)
After-Hours: 20:00
Universe Pharmaceuticals Revenue (TTM): 32.31M for Sept. 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 32.31M |
| March 31, 2023 | 34.41M |
| September 30, 2022 | 40.14M |
| March 31, 2022 | 47.89M |
| September 30, 2021 | 47.98M |
| Date | Value |
|---|---|
| March 31, 2021 | 38.61M |
| September 30, 2020 | 30.70M |
| March 31, 2020 | 31.49M |
| September 30, 2019 | 33.23M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
30.70M
Minimum
Sep 2020
47.98M
Maximum
Sep 2021
37.42M
Average
34.41M
Median
Mar 2023
Revenue (TTM) Benchmarks
| Sinovac Biotech Ltd | 448.27M |
| CASI Pharmaceuticals Inc | 33.88M |
| Zai Lab Ltd | 266.72M |
| I-MAB | 3.914M |
| Gracell Biotechnologies Inc (DELISTED) | -- |